Scripps Health

Running trials

• Recruiting

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  NCT07221500· Phase 2· Nurix Therapeutics, Inc.· Source

• Recruiting

  Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

  NCT07065721· San Diego State University· Source

• Recruiting

  A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

  NCT06764940· Phase 2· Biostar Pharma, Inc.· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  NCT06790693· Phase 3· Hoffmann-La Roche· Source

• Enrolling by invitation

  Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

  NCT06560021· Abramson Cancer Center at Penn Medicine· Source

• Recruiting

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· Phase 3· Kartos Therapeutics, Inc.· Source

• Recruiting

  A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  NCT06112418· Cleerly, Inc.· Source

• Recruiting

  Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  NCT06293898· Phase 1· SystImmune Inc.· Source

• Enrolling by invitation

  Phase 1/2a Study of ANPD001 in Parkinson Disease

  NCT06344026· Phase 1· Aspen Neuroscience· Source

• Active, not recruiting

  Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)

  NCT06181240· Bolt Medical· Source

• Recruiting

  The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  NCT05836987· Phase 3· Johns Hopkins University· Source

• Active, not recruiting

  REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage Study

  NCT05611918· Johns Hopkins University· Source

• Active, not recruiting

  ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

  NCT05686317· Edwards Lifesciences· Source

• Active, not recruiting

  An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

  NCT05565599· Jaguar LAA, Inc.· Source

• Recruiting

  HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

  NCT06425848· University of Kansas Medical Center· Source

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

  NCT05306340· Phase 3· Genentech, Inc.· Source

• Active, not recruiting

  A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  NCT05100862· Phase 3· BeOne Medicines· Source

• Recruiting

  Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

  NCT04592445· Axon Therapies, Inc.· Source

• Active, not recruiting

  Amplatzer Amulet LAAO vs. NOAC

  NCT04226547· Abbott Medical Devices· Source

• Active, not recruiting

  ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

  NCT03973372· University of Texas Southwestern Medical Center· Source

• Active, not recruiting

  Reducing Lung CongestIon Symptoms in Advanced Heart Failure

  NCT03499236· V-Wave Ltd· Source

• Recruiting

  The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  NCT03142152· Cardiac Dimensions, Inc.· Source

• Active, not recruiting

  LEADERS FREE II: BioFreedom™ Pivotal Study

  NCT02843633· Biosensors Europe SA· Source

• Active, not recruiting

  Genomic Investigation of Cardiovascular Diseases

  NCT00722748· Scripps Translational Science Institute· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure3 recruiting
• Type 2 diabetes2 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Brain metastases1 recruiting
• Cervical cancer1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Ovarian cancer1 recruiting
• Parkinson disease1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Terminated

  A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

  NCT05556616· Phase 1· Teva Branded Pharmaceutical Products R&D LLC· Source

• Terminated

  CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

  NCT05207722· Phase 1/2· Celularity Incorporated· Source

• Completed

  AMPLATZER™ Amulet™ LAA Occluder Trial

  NCT02879448· Abbott Medical Devices· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Eosinophilic oesophagitis3 works · 0 trials